BRAFV600E-mutated Ovarian Serous Borderline Tumors Are at Relatively Low Risk for Progression to Serous Carcinoma
Oncotarget - United States
doi 10.18632/oncotarget.27326
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 6, 2019
Authors
Publisher
Impact Journals, LLC